MENU

AMED Stock Amedisys (AMED, $93.56) price exceeded its 50-day Moving Average on February 05, 2024

A.I.dvisor
at Tickeron.com
02/06/24
Loading...
AMED - Amedisys
Moving Avg. signal
Bearish Trend
Odds of DOWN Trend
Tickeron
Moving Avg. signal
Price: $93.56
Daily change: -$1.11 (-1.17%)
Daily volume: 196.2K
Industry: Medical/Nursing Services
This price move could indicate a change in the trend, and may be a sell signal for investors. A.I.dvisor found 46 similar cases, and were successful. Based on this data, the odds of success are

AMED's Indicator enters downward trend

The Aroon Indicator for AMED entered a downward trend on October 11, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 185 similar instances where the Aroon Indicator formed such a pattern. In of the 185 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on November 07, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on AMED as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AMED's RSI Oscillator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMED just turned positive on November 06, 2024. Looking at past instances where AMED's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

AMED moved above its 50-day moving average on November 06, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMED advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMED’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.830) is normal, around the industry mean (4.471). AMED's P/E Ratio (1170.500) is considerably higher than the industry average of (71.137). Projected Growth (PEG Ratio) (1.377) is also within normal values, averaging (1.595). AMED has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (1.347) is also within normal values, averaging (20.337).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

View a ticker or compare two or three
AMED
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of home health care nursing services

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
3854 American Way
Phone
+1 225 292-2031
Employees
19000
Web
https://www.amedisys.com